Medicus Pharma Ltd Announces A Binding Letter Of Intent To Acquire Antev Ltd. For ~ Us $75 Million In A Share Exchange Transaction
Philadelphia, Pennsylvania––April 29, 2025 – Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus“) and Antev Ltd. (“Antev“), a UK-based late clinical-stage drug development company, announced on 28 April that they have entered into…